Antitumor Mechanism and Therapeutic Potential of Cordycepin Derivatives
Molecules · 18.01.2024 · 29 (2) · 483
DOI: 10.3390/molecules29020483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 18.01.2024. Verfasst von Linlin Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Harbin University of Commerce, Harbin 150076, China. Hauptthemen laut MEDLINE: Deoxyadenosines, Apoptosis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Postdoctoral Project of Heilongjiang Province, Harbin University of Commerce.
Abstract (Originalsprache)
Cordycepin has good antitumor activity, but its clinical application is limited due to the easy deamination of N6 in structure. In this study, a large lipolysis group was introduced at the cordycepin N6 to improve the problem, cordycepin derivatives (3a–4c) were synthesized, and biological evaluation of compounds was studied. In this study, the vitro antitumor activity of the compounds against MCF7 cells, HepG2 cells and SGC-7901 cells was evaluated by MTT assay. In the results, compound 4a showed the most obvious inhibitory effect on MCF7 cells with an IC50 value of 27.57 ± 0.52 μM, which was much lower than cordycepin. Compound 4a showed high selectivity between MCF7 and normal MCF-10A cells. Further biological evaluation showed that compound 4a promoted apoptosis and blocked the cell cycle in the G0/G1 phase. Then, Western Blot was used to detect related apoptotic proteins. It was found that Compound 4a could down-regulate the expression of Bcl-2 protein and up-regulate the expression of p53, Bax, Caspase-3 and Caspase-9 proteins. The mitochondrial membrane potential decreased continuously and the positive expression rate decreased. It was speculated that compound 4a induced the apoptosis of MCF7 cells through the mitochondrial pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Harbin University of Commerce, Harbin 150076, China.
- Heilongjiang Provincial Key Laboratory of Drug Prevention and Treatment for Senile Diseases, Harbin 150076, China.
ORCID-Profile: Linlin Cui
Förderung
- Postdoctoral Project of Heilongjiang Province
- Harbin University of Commerce
Zitieren
APA
Cui, L., Zhao, L., Shen, G., Yu, D., Yuan, T., Zhang, Y., & Yang, B. (2024). Antitumor Mechanism and Therapeutic Potential of Cordycepin Derivatives. Molecules, 29(2), 483. https://doi.org/10.3390/molecules29020483
Vancouver
Cui L, Zhao L, Shen G, Yu D, Yuan T, Zhang Y, et al. Antitumor Mechanism and Therapeutic Potential of Cordycepin Derivatives. Molecules. 2024;29(2):483. doi:10.3390/molecules29020483
BibTeX
@article{Cui2024,
author = {Cui, Linlin and Zhao, Li and Shen, Guanghuan and Yu, Dahai and Yuan, Tian and Zhang, Yingyu and Yang, Bo},
title = {Antitumor Mechanism and Therapeutic Potential of Cordycepin Derivatives},
journal = {Molecules},
year = {2024},
volume = {29},
number = {2},
pages = {483},
doi = {10.3390/molecules29020483}
}
EUVIMED